EVH Q3 2026 deep dive: ongoing AI investment and customer expansion shape outlook
Evolent Health, Inc. (EVH) Q3 2026 Earnings Call Transcript
What Evolent Health (EVH) Said on Its Q3 Earnings Call
Oppenheimer Maintains Outperform on Evolent Health, Raises Price Target to $7
Evolent Health, Inc. Q3 2026 Earnings Call Summary
Evolent Health, Inc. Reports Third Quarter 2026 Financial Results
Evolent Health (EVH) Q3 2026 Earnings Call Transcript
Needham Maintains Buy on Evolent Health, Raises Price Target to $6
Evolent Health (NYSE:EVH) Q3 2026 Earnings: In-Line Revenue, EPS Beat, but Premarket Shares Slide
Evolent Health (EVH) Matches Q3 Earnings Estimates
Compared to Estimates, Evolent Health (EVH) Q3 Earnings: A Look at Key Metrics
Evolent Health: Q3 Earnings Snapshot
Evolent Announces Third Quarter 2026 Results
Evolent Health Q3 2026 Earnings Call Transcript
Evolent Health Affirms FY2026 Sales Guidance of $2.600B-$2.700B vs $2.626B Est
Evolent Health Q3 Adj. EPS $0.06 Beats $0.05 Estimate, Sales $725.367M Beat $724.186M Estimate
Evolent To Release Third Quarter 2026 Financial Results on Thursday, November 5, 2026
3 Reasons to Avoid EVH and 1 Stock to Buy Instead
Q2 Healthcare Technology for Providers Earnings: Evolent Health (NYSE:EVH) Impresses
JP Morgan Maintains Overweight on Evolent Health, Raises Price Target to $6
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.